Twitter

Dr. Michael Rotkowitz on the Dabrafenib Plus Trametinib Combination for Melanoma

Michael Rotkowitz, MD, medical oncologist, Cancer Treatment Centers of America, Eastern Regional Medical Center, discusses bypassing resistance in patients with melanoma that are receiving vemurafenib. Read more at www.onclive.com

http://www.youtube.com/v/ZZ4SZwBbOi4?version=3&f=videos&app=youtube_gdata

View original post here: Dr. Michael Rotkowitz on the Dabrafenib Plus Trametinib Combination for Melanoma




Comments are closed.